Lafayette Investments’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-15,700
| Closed | -$145K | – | 89 |
|
|
2019
Q2 | $145K | Hold |
15,700
| – | – | 0.05% | 84 |
|
|
2019
Q1 | $246K | Hold |
15,700
| – | – | 0.09% | 76 |
|
|
2018
Q4 | $242K | Buy |
15,700
+300
| +2% | +$4.62K | 0.1% | 77 |
|
|
2018
Q3 | $332K | Sell |
15,400
-3,050
| -17% | -$65.8K | 0.11% | 66 |
|
|
2018
Q2 | $449K | Buy |
18,450
+600
| +3% | +$14.6K | 0.16% | 55 |
|
|
2018
Q1 | $305K | Buy |
17,850
+1,949
| +12% | +$33.3K | 0.11% | 61 |
|
|
2017
Q4 | $301K | Buy |
15,901
+1,500
| +10% | +$28.4K | 0.11% | 62 |
|
|
2017
Q3 | $253K | Buy |
14,401
+4,400
| +44% | +$77.3K | 0.09% | 66 |
|
|
2017
Q2 | $332K | Buy |
10,001
+1,400
| +16% | +$46.5K | 0.12% | 55 |
|
|
2017
Q1 | $276K | Buy |
8,601
+950
| +12% | +$30.5K | 0.1% | 58 |
|
|
2016
Q4 | $277K | Buy |
7,651
+2,400
| +46% | +$86.9K | 0.11% | 57 |
|
|
2016
Q3 | $242K | Buy |
5,251
+200
| +4% | +$9.22K | 0.1% | 59 |
|
|
2016
Q2 | $254K | Hold |
5,051
| – | – | 0.1% | 58 |
|
|
2016
Q1 | $270K | Buy |
5,051
+51
| +1% | +$2.73K | 0.11% | 58 |
|
|
2015
Q4 | $328K | Sell |
5,000
-250
| -5% | -$16.4K | 0.14% | 55 |
|
|
2015
Q3 | $296K | Hold |
5,250
| – | – | 0.13% | 58 |
|
|
2015
Q2 | $310K | Hold |
5,250
| – | – | 0.13% | 56 |
|
|
2015
Q1 | $327K | Hold |
5,250
| – | – | 0.14% | 57 |
|
|
2014
Q4 | $302K | Sell |
5,250
-100
| -2% | -$5.75K | 0.13% | 58 |
|
|
2014
Q3 | $288K | Sell |
5,350
-50
| -0.9% | -$2.69K | 0.13% | 56 |
|
|
2014
Q2 | $283K | Hold |
5,400
| – | – | 0.12% | 57 |
|
|
2014
Q1 | $285K | Sell |
5,400
-150
| -3% | -$7.92K | 0.13% | 56 |
|
|
2013
Q4 | $222K | Buy |
+5,550
| New | +$222K | 0.1% | 62 |
|